Not applicableUnknownNCT00449319What this trial is testingAML Treatment in Untreated Adult PatientsWho this might be right forLeukemia, Myelocytic, Acute Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicableUnknownNCT03531931What this trial is testingApatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot TrialWho this might be right forProgression-free Survival;Progression-free Survival;Disease Control Rate; Safety The First Affiliated Hospital of Xiamen University 20
Not applicableEnded earlyNCT02485353What this trial is testingStudy of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AMLWho this might be right forLeukemia, Myeloid, Acute Hamid Sayar 2
Testing effectiveness (Phase 2)Looking for participantsNCT07448142What this trial is testingLow-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal CancerWho this might be right forColorectal Cancer (CRC) Sun Yat-sen University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07591831What this trial is testingLiposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian CancerWho this might be right forPlatinum-resistant Recurrent Ovarian CancerFallopian Tube CancersEpithelial Ovarian Cancer+1 more Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT05673967What this trial is testingReal-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple MyelomaWho this might be right forRelapsed and Refractory Multiple Myeloma (RRMM) Regeneron Pharmaceuticals 62
Testing effectiveness (Phase 2)Ended earlyNCT00474188What this trial is testingEvaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-cell Lymphoma Celgene Corporation 26
Not applicableStudy completedNCT05307926What this trial is testingPostoperative Adjuvant Therapy of HCC Based on PD-1Who this might be right forHepatocellular CarcinomaRFS Chen Xiaoping 573
Not applicableStudy completedNCT01279304What this trial is testingRadiotherapy After Primary Chemotherapy for BreastcancerWho this might be right forBreast Cancer Maastricht Radiation Oncology 851
Testing effectiveness (Phase 2)Study completedNCT01116271What this trial is testingStudy of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With ColorecWho this might be right forColorectal Cancer AstraZeneca 32
Large-scale testing (Phase 3)Looking for participantsNCT07426094What this trial is testingPRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate CancerWho this might be right forProstate CancerBrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,600
Testing effectiveness (Phase 2)UnknownNCT04782765What this trial is testingPhase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal CarcinomaWho this might be right forDisease-free Survival Rate Tianjin Medical University Cancer Institute and Hospital 59
Not applicableStudy completedNCT07442110What this trial is testingThis Observational Study Evaluates the Clinical Outcomes of Patients With Diabetes Who Utilize a Specialized Dietary Supplements for Foot Ulcer Healing. The Study Documents the Rate of Complete Wound Closure and the Prevention of Lower Extremity Amputations in a Real-world, At-home Setting.Who this might be right forLimb SalvageDiabetes ComplicationDietary Supplements+6 more Amar h Zireg 35
Testing effectiveness (Phase 2)UnknownNCT00839111What this trial is testingSorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin TreatmentWho this might be right forColorectal Neoplasms Fudan University 43
Testing effectiveness (Phase 2)Looking for participantsNCT06276868What this trial is testingDarsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast CancerWho this might be right forBreast CancerHER2-positive Breast Cancer Henan Cancer Hospital 71
Not applicableStudy completedNCT05754047What this trial is testingTumor Characteristics and Survival Rate of HER2-Low Breast Cancer PatientsWho this might be right forHER2 Low Breast Carcinoma Mahdis Bayat 3,582
Testing effectiveness (Phase 2)UnknownNCT04664244What this trial is testingCombination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous CarcinomaWho this might be right forRecurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more Lei Li 43
Post-approval studies (Phase 4)UnknownNCT05229809What this trial is testingClinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric CancerWho this might be right forGastric Carcinoma Jie Li 212
Not applicableStudy completedNCT06989346What this trial is testingImpact of Perioperative Hyperoxia on Cancer Recurrence and Mortality After Elective Colorectal Cancer SurgeryWho this might be right forRecurrenceSurvival RateMortality+2 more Parc de Salut Mar 403
Not applicableUnknownNCT04870567What this trial is testingHDR Brachytherapy vs SABR in Early-intermediate Prostate CancerWho this might be right forBiochemical Relapse Free SurvivalComplications Rates (Erectile Dysfunction, GI, GU Complications) N.N. Petrov National Medical Research Center of Oncology 350